DIA
Drug Information Association Logo

GLOBAL DEVELOPMENT AND SUPPLY

Track:
Globalisation/Inspections

Day & Time:
March 26, 2:00PM - 3:30PM (Central European Standard Time)

Session Number:
1003

Room Number:
Room LM

Type:
Session

Title:
GLOBAL DEVELOPMENT AND SUPPLY

Chair(s):
Frederic Bourgeois
Associate Vice President Global Quality Supply Chain
Sanofi Winthrop Industrie, France

Description:
This session will look at complexities of supply chain from both a regulatory and Quality/GMP perspective with examples and case studies. Then we will explore the potential link between supply chain issues and drug shortages.

Presentation(s) & Speaker(s):
Effects of complex supply chains on the regulatory strategy for emerging markets
Kirsten Jacobs, DrSc
Vice President, Head of Regulatory and Quality
Pharmalex, Germany

Supply Shortages of Medicines in Europe: patient perspective
David Haerry
Member of Board of Directors
European AIDS Treatment Group, Belgium

Quality/GMP Perspective on Supply Chain Issues – European generic medicines industry view
Gerd Fischer
Quality Manager
Boehinger-Ingelheim GmbH, Germany

Quality/GMP Perspective on Supply Chain Issues – European generic medicines industry view
Julie Marechal-Jamil, MSc
Sr. Manager Quality & Regulatory Affairs
European Generics medicines Association (EGA), Belgium